Free Trial

HilleVax (HLVX) SEC Filings & 10K Form

HilleVax logo
$1.88 -0.04 (-2.08%)
As of 10:01 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent HilleVax SEC Filings

DateFilerForm TypeView
04/30/2025
6:30 AM
HilleVax (Filer)
Form ARS
04/30/2025
6:35 AM
HilleVax (Filer)
Form DEFA14A
04/30/2025
6:40 AM
HilleVax (Filer)
Form DEF 14A
04/30/2025
6:00 AM
Heron Patrick J (Reporting)
HilleVax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:00 AM
HilleVax (Issuer)
Sepulveda Jaime (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:00 AM
HILLEMAN JERYL L (Reporting)
HilleVax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:00 AM
Gerberding Julie L. (Reporting)
HilleVax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:00 AM
Cocero Nanette (Reporting)
HilleVax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:00 AM
Chu Shelley (Reporting)
HilleVax (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
4:05 PM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
3:05 PM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:36 AM
Deep Track Capital, LP (Filed by)
HilleVax (Subject)
Form SC 13G/A
11/14/2024
8:00 AM
Flynn James E (Filed by)
HilleVax (Subject)
Form SC 13G/A
11/07/2024
7:10 AM
HilleVax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:05 AM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:40 PM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
6:34 PM
HilleVax (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2024
3:05 PM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2024
3:45 PM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
8:02 PM
HilleVax (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
07/08/2024
6:40 AM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:57 PM
FHMLS X, L.L.C. (Reporting)
FHMLS X, L.P. (Reporting)
Frazier Life Sciences X, L.P. (Reporting)
Heron Patrick J (Reporting)
HilleVax (Issuer)
Topper James N (Reporting)
Form 4/A
05/31/2024
1:00 PM
Frazier Life Sciences Public Fund, L.P. (Filed by)
HilleVax (Subject)
Form SC 13D/A
05/22/2024
4:40 PM
HilleVax (Issuer)
Kohli Aditya (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
11:15 PM
HilleVax (Filer)
Form EFFECT
05/09/2024
3:10 PM
HilleVax (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HLVX) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners